HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthias Echternach Selected Research

Succinylcholine (Suxamethonium Chloride)

3/2006Rocuronium is not associated with more vocal cord injuries than succinylcholine after rapid-sequence induction: a randomized, prospective, controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthias Echternach Research Topics

Disease

4COVID-19
07/2022 - 12/2020
2Wounds and Injuries (Trauma)
03/2006 - 01/2006
2Hoarseness
03/2006 - 01/2006
1Carcinoma (Carcinomatosis)
03/2023
1Neoplasms (Cancer)
03/2023
1Specific Language Disorder
12/2021
1Dysphonia (Spastic Dysphonia)
05/2021
1Voice Disorders (Voice Disturbances)
01/2021
1Pathologic Dilatation (Ectasia)
07/2014
1Neoplasm Metastasis (Metastasis)
02/2009
1Melanoma (Melanoma, Malignant)
02/2009
1Myalgia
03/2006
1Pharyngitis (Sore Throat)
03/2006

Drug/Important Bio-Agent (IBA)

4AerosolsIBA
07/2022 - 12/2020
1GATIBA
01/2021
1Mitomycin (Mitomycin-C)FDA LinkGeneric
02/2009
1Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric
03/2006
1Rocuronium (Zemuron)FDA LinkGeneric
03/2006

Therapy/Procedure

2Therapeutics
07/2014 - 02/2009
2General Anesthesia
03/2006 - 01/2006
1Laryngoplasty
03/2023
1Speech Therapy (Therapy, Speech)
12/2021
1Voice Training
05/2021